Literature DB >> 11416724

Declining incidence of visceral leishmaniasis in HIV-infected individuals in the era of highly active antiretroviral therapy.

E Rosenthal1, S Tempesta, P Del Giudice, P Marty, P Desjeux, C Pradier, Y Le Fichoux, J P Cassuto.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11416724     DOI： 10.1097/00002030-200106150-00017

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  8 in total

1.  Leishmaniasis as an opportunistic infection in HIV-infected patients: determinants of relapse and mortality in a collaborative study of 228 episodes in a Mediterreanean region.

Authors:  F Pasquau; J Ena; R Sanchez; J M Cuadrado; C Amador; J Flores; C Benito; C Redondo; J Lacruz; V Abril; J Onofre
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-06       Impact factor: 3.267

2.  Nelfinavir, an HIV-1 protease inhibitor, induces oxidative stress-mediated, caspase-independent apoptosis in Leishmania amastigotes.

Authors:  Pranav Kumar; Robert Lodge; Nathalie Trudel; Michel Ouellet; Marc Ouellette; Michel J Tremblay
Journal:  PLoS Negl Trop Dis       Date:  2010-03-30

3.  Human immunodeficiency virus and leishmaniasis.

Authors:  Navid Ezra; Maria Teresa Ochoa; Noah Craft
Journal:  J Glob Infect Dis       Date:  2010-09

Review 4.  The relationship between leishmaniasis and AIDS: the second 10 years.

Authors:  Jorge Alvar; Pilar Aparicio; Abraham Aseffa; Margriet Den Boer; Carmen Cañavate; Jean-Pierre Dedet; Luigi Gradoni; Rachel Ter Horst; Rogelio López-Vélez; Javier Moreno
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

Review 5.  The immunology of Leishmania/HIV co-infection.

Authors:  Ifeoma Okwor; Jude Eze Uzonna
Journal:  Immunol Res       Date:  2013-05       Impact factor: 2.829

Review 6.  Aspartic peptidases of human pathogenic trypanosomatids: perspectives and trends for chemotherapy.

Authors:  L O Santos; A S Garcia-Gomes; M Catanho; C L Sodre; A L S Santos; M H Branquinha; C M d'Avila-Levy
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

7.  Visceral leishmaniasis due to Leishmania infantum with renal involvement in HIV-infected patients.

Authors:  Matteo Vassallo; Olivier Moranne; Damien Ambrosetti; Pierre-Yves Jeandel; Christelle Pomares; Elisabeth Cassuto; Annick Boscagli; Guillaume Giraud; Nathalie Montagne; Chiara Dentone; Ilaria Demacina; Barbara Villaggio; Giovanni Secondo; Giuseppe Ferrea; Corinne Passeron; Laurence Saudes; Regis Kaphan; Pierre Marty; Eric Rosenthal
Journal:  BMC Infect Dis       Date:  2014-10-30       Impact factor: 3.090

8.  Visceral leishmaniasis and immunocompromise as a risk factor for the development of visceral leishmaniasis: a changing pattern at the hospital for tropical diseases, london.

Authors:  Kate Fletcher; Rita Issa; D N J Lockwood
Journal:  PLoS One       Date:  2015-04-01       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.